Publication | Closed Access

Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone

Schizophrenic PatientsPsychoactive DrugPsychiatryPsychotic DisorderStressMedicinePsychopharmacologySchizophreniaClinical FindingsToxicologyBiological PsychiatryOxidative Stress MarkersPharmacologySocial SciencesOxidative Stress